【摘要】 目的：探讨CTGF对糖尿病大鼠视网膜内细胞凋亡的影响。方法：将60大鼠分为对照组，糖尿病4，8，12，16wk组和干预组。糖尿病大鼠应用STZ腹腔注射诱导成模。干预组大鼠于糖尿病成模后16wk玻璃体腔注射CTGFsiRNA来造成CTGF基因的沉默。取各组视网膜组织，应用RT-PCR检测视网膜内的CTGF基因表达，Tunnel法检测视网膜凋亡细胞的情况。结果：糖尿病组视网膜内CTGF表达和凋亡细胞数较正常组明显增加。凋亡发生在建模后4wk，并随着时间的延长而加重，在24wk时，凋亡细胞数为25.8个/mm2。CTGF表达于8wk时出现升高，到16wk时升高更明显。CTGFsiRNA处理后凋亡细胞数明显降低。视网膜内CTGF和细胞凋亡之间具有明显的相关性。结论：CTGF参与了糖尿病视网膜早期病变的细胞凋亡机制，CTGFsiRNA有利于改善糖尿病早期视网膜由于凋亡所致的细胞丢失。
【关键词】 凋亡; CTGF; 视网膜; 糖尿病
CTGFsiRNA ameliorates retinal cells apoptosis in the streptozotocininduced diabetic rat
HongWei Yang, XiaoLong Chen, ZheLi Liu, Jie Liu, LiMin Bu
Foundation item：Supported by the Educational Office of Liaoning Province ，China(No.20060994)
Department of Ophthalmology, the Affiliated Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province,China
Correspondence to: HongWei Yang. Department of Ophthalmology, the Affiliated Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province，China.yanghw@sjhospital.org
AbstractAIM: To detect the effect of CTGF on the apoptosis in the diabetic retina with small interfering RNAs (siRNA) targeting with CTGF.
METHODS: A total of 60 rats were divided into six groups including control group, diabetic 4,8,12,16 weeks group, and interference group. Diabetic rats were induced by STZ intraperitoneal. At 4, 8, 12, 16 weeks after diabetic setting up, retinas were obtained from control, diabetic rats and diabetic animals treated by intravitreal injection of CTGFsiRNA to suppress the expression of CTGF mRNA. Retinal cells apoptosis was detected by Tunnel staining and mRNA expression of CTGF was analyzed by RTPCR.RESULTS: The levels of CTGF and the apoptosis in the retinas of diabetic rats were significantly higher than those in the controls. Apoptosis occurred at 4 weeks after a diabetic model setting up, became serious with the diabetes developing, while CTGF elevated at 8 weeks. The cell apoptosis counts increased to 25.8cells/mm2 at 24 weeks of diabetes. SiRNAmediated inhibition of CTGF mRNA resulted in a significant decrease in apoptosis. Significant correlations were found between CTGF and apoptosis in the retina.
CONCLUSION: These results suggest that CTGF might be involved in retinal cells apoptosis which is a characteristic of early diabetic retina. siRNA targeting CTGF seems to have the advantage of ameliorating retinal cells lost.
KEYWORDS: apoptosis; CTGF; retina; diabetets
DOI:10.3969/j.issn.16725123.2010.05.002
INTRODUCTION
Diabetic retinopathy is one of the most common complications of diabetes and a leading cause of vision loss, ultimately resulting in an advanced stage of proliferative retinopathy with neovascularization, fibrovascular proliferation and retinal detachment. At the cellular level, diabetes alters the function and structure of all retinal cell types[1]. The pathogenesis of diabetic retinopathy includes glucosemediated microvascular damage[24] and alterations of the neural retina，impaired glial reactivity and apoptotic cell death of retinal cells have been observed in cases of shortterm experimental diabetes and in humans with diabetes[5]. Animal studies show accelerated apoptosis of retinal neurons[6], glial activation[7], microvascular cells[8], photoreceptors[9] and microglial cell[10]. It is important to characterize the early pathological processes in the diabetic neural retina before the onset of vascular pathology. More recently, a novel, cysteine rich secreted protein CTGF has been associated with diabetic retinopathies, which is postulated to have prosclerotic，angiogenic and apoptosis induction[11] properties[12] in other tissues. However, there have been few previous reports that have linked the elevated expression of CTGF in diabetic retinas to pathological changes. To investigate the role of diabetesenhanced CTGF expression in retinal cell apoptosis, diabetic rats were treated with CTGFsiRNA intravitreal injection.
MATERIALS AND METHODS
Materials Wistar rats were purchased from Animal Laboratories of China Medical University. Throughout the study animals were given access to food and water in metabolic cages. All animal procedures were in accordance with guidelines set by the Animal Experiment Committee of the China Institutes for Biological Sciences. Wistar rats, male, weighing 180200g, were randomly divided into six groups: control group, diabetic groups at 4 weeks (DM4W), 8 weeks (DM8W), 16 weeks (DM16W), 24 weeks (DM24W) and DM16W interfered with CTGFsiRNA group (n=10) .
Methods
Streptozotocininduced diabetic rat model Experimental diabetes was induced by intraperitoneal injection of βcell toxin streptozotocin (60mg/kg). Immediately prior to use, streptozotocin was dissolved in cold 0.1mol/L citrate buffer, pH 4.5. Control rats received an injection of 0.1mol/L citrate buffer alone. Blood glucose (BG) levels were measured before and 72 hours after the STZ injection, urinary glucose (UG) measured consequently the first three days. Only the animals with UG above +++,blood glucose levels >16.7mmol/L were considered diabetes. Body weight, UG, BG and glycated hemoglobin were measured weekly. At 4, 8, 16, 24 weeks of diabetes, ten rats were randomly selected from the normal control and diabetic groups and killed with a lethal dose of pentobarbital sodium. Eyes from each rat were rapidly enucleated, one being snapfrozen in liquid nitrogen and stored in 80℃ for the consequent RTPCR, while the contralateral eye was fixed at 40g/L paraformaldehyde for apoptosis and immunohistochemistry.Table 1The sequences of the siRNAs targeting rat CTGF gene(略)Table 2General characteristics of nondiabetic and diabetic rats at 4, 8, 16 and 24 weeks after STZ injection(略)
Preparation of CTGFsiRNA A doublestranded rat CTGFsiRNA were synthesized by personnel at GenePharma (Shanghai, China), as described previously[13,14]. The sequence of siRNAs targeting rat CTGF gene are shown in Table 1. The resultant siRNA was purified, quantified and suspended in water at a concentration of 50ng/μL, and 0.5μL (10 picomoles) siRNA for CTGF was combined with 0.5μL siRNA transfection reagent (GenePharma Co. Ltd. Shanghai, China) for 20 minutes before injection according to the manufacturers instructions. Control injection was 1.0μL PBS. The doses of CTGFsiRNA used in the present study were chosen according to studies.
Intravitreous injections Ten diabetic rats at 16 weeks after the diabetic model setting up were performed intravitreal injection eyes as previously described[15]. Rats were anesthetized with an intraperitoneal injection of 65mg/kg pentobarbital sodium (Sigma, USA). A topical anesthetic (5g/L tetracaine hydrochloride, Santen, Japan) was administered and the pupils were dilated with 10g/L tropicamide before inserting a 30gauge needle just 2.0mm posterior to the limbus to avoid lens damage. 1.0μL CTGFsiRNA was injected in right eyes using a 1mL Hamilton syringe. All fellow eyes were injected with Control injections. Then 5g/L topical TobraDex ointment (Alcon, USA) applied to the injected eye for preventing the infection. Rats were killed 1 day later, and the eyes were removed. CTGF mRNA levels and apoptosis were examined in retinas.
RNA Extraction and Reverse Transcriptionpolymerase Chain Reaction Retina tissues were collected from different groups. RNA was extracted from the retina using Trizol (Invitrogen), RTPCR was performed according to the manufacturers instructions. PCR protocol: 2 minutes at 94℃, followed by 32 cycles of 30 seconds at 94℃, 30 seconds at 56℃ and 1 minute at 72℃, 2 minutes at 72℃. Relative concentrations of DNA in each specimen was semiquantitated on an Automated Imaging System (Alphainnotech ChemiImager 5500, USA) by the integral density of the product bands, which was then normalized to the density of βactin. The data are expressed as the mean transcript/βactin ratio±SD.The primer of CTGF:5TGTGAAGACATACAGGGCTAA3 5GTTCTCACTTTGGTG GGATAG3.
In situ Cell Death Detection Apoptotic cells were detected by TUNEL assay with an In Situ Cell Apoptosis Detection Kit (Boster, Wuhan, China) according to the kit manufacturers instructions. After deparaffinization, the sections were treated with proteinase K, incubated with TUNEL reaction mixture and peroxidaseconjugated antibody, stained with the diaminobenzidine solution.To quantify the number of TUNELlabeled nuclei, we obtained counts and averaged them from five different randomly selected areas of a given coverslip, using an eyepiece graticule grid that represented an area of 400μm×400μm. Thus, to convert values to cells/mm2, each averaged value multiplied by 6.25 (ie. 2.5×2.5). Ten coverslips were analyzed for each treatment and values statistically compared for differences.
Statistical Analysis All data were expressed as the mean±standard deviation (SD). Statistical analysis was performed by a Students ttest using special software (SPSS for windows, ver. 10.0; SPSS, Inc.). P<0.05 was considered significant.
RESULTS
Animal Characteristics Fifty rats were intraperitoneal injection of the βcell toxin streptozotocin (60mg/kg). All the animals with UG above +++, blood glucose levels >16.7mmol/L were induced to diabetes. The mean weight, blood glucose, was significantly different between nondiabetic and diabetic animals(Table 2).Diabetic rats gained hyperglycemia and increased urinary glucose compared with the normal rats of the control group. At 4 weeks there is no significant effect on body weight and from 8 weeks on, the difference is significant. Throughout the experiment, it was not noted of inflammation, retinal detachment, or vitreous hemorrhage in any of the rats.
Effect of Diabetes on CTGF We compared with CTGF mRNA expression levels of different groups. There was seldom in the normal retina and DM4W group, and became stronger in diabetic rat in DM8W (P<0.05). CTGF expression levels were increased twofold. DM16W and DM24W (P<0.01) groups steadily. Figure 1 shows CTGF gene expression in the retina. The statistical analysis demonstrates that CTGF mRNA expression in the diabetic retina is up regulated. The difference is significant shown in the Figure 1(aP<0.05,bP<0.01). The error bars show the standard deviation for each group. CTGFsiRNA was injected intravitreously in diabetic rats to make the CTGF gene silence. So we chose 16week groups to inhibit the CTGF expression by intravitreal CTGFsiRNA injection. The results of these experiments showed that the inhibitory efficiency of CTGFsiRNA were 55%. Such inhibition of gene expression were significant (P<0.01), as determined by Students ttest.
[1] [2] [3] 下一页 |
